entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
730102,CRYZL2P,transcribed_pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,17.5844845706952,-0.403715637999402,0.507854088946084,-0.794944151847248,0.426645989631988,0.961473650102656,NA
730102,CRYZL2P,transcribed_pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,20.632017941195,0.12316866824421,0.404674431532669,0.30436483910713,0.760849952168209,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
730102,CRYZL2P,transcribed_pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,171.221934713761,-0.660924183107762,0.187302734700746,-3.52864139524562,0.000417698736140221,0.00316978635454502,A549
730102,CRYZL2P,transcribed_pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,149.598981866565,0.0511491223616382,0.185555336592526,0.275654278130304,0.782813616179379,0.986418245486816,A549
730102,CRYZL2P,transcribed_pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,95.8640375628456,-4.27281970974519,0.466519922809473,-9.15892226855704,5.24181838707729e-20,9.17411223742554e-19,A549
730102,CRYZL2P,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,899.265994301841,-0.00274431954548504,0.275797230874007,-0.00995049709813342,0.99206078300678,1,sigmoid colon organoid
730102,CRYZL2P,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,899.265994301841,-0.144993745036955,0.275894136263513,-0.525541234767193,0.599206996111583,1,sigmoid colon organoid
